25: Mike Klein on The Future of Genomics and Precision Medicine

If it’s part of your DNA, is it something that you can change? For the longest time the answer to that question has been no, but now that’s not necessarily the case. Genetics is a world that is evolving at a rapid pace. And with a lot of new data coming out in the field, there is a growing need to sort that data and make it actionable. That’s what this week’s guest is doing. Genomenon is a genomic health IT company that connects genomic data with patient DNA in order to help diagnose and treat those with rare genetic cancers and diseases. They do this by providing their customers with tools to solve previously unsolvable mysteries. We sat down with Mike Klien, the CEO of Genomenon to explore the impact that their work is having on the health industry, and within the genetics market.

Learn more about Genomenon: https://www.genomenon.com